Kate I Patterson

Summary

Affiliation: Garvan Institute of Medical Research
Country: Australia

Publications

  1. ncbi request reprint Dual-specificity phosphatases: critical regulators with diverse cellular targets
    Kate I Patterson
    Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst 2010, Sydney, NSW, Australia
    Biochem J 418:475-89. 2009
  2. doi request reprint DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs
    Kate I Patterson
    Garvan Institute of Medical Research, Darlinghurst, NSW, 2010 Australia
    Biochim Biophys Acta 1803:1003-12. 2010
  3. doi request reprint Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers
    Brian S Gloss
    Cancer Research Program, The Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia
    Cancer Lett 318:76-85. 2012

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Dual-specificity phosphatases: critical regulators with diverse cellular targets
    Kate I Patterson
    Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst 2010, Sydney, NSW, Australia
    Biochem J 418:475-89. 2009
    ..The present review provides an overview of the DUSP family before focusing on atypical DUSPs, emerging as a group of proteins with vastly diverse substrate specificity and function...
  2. doi request reprint DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs
    Kate I Patterson
    Garvan Institute of Medical Research, Darlinghurst, NSW, 2010 Australia
    Biochim Biophys Acta 1803:1003-12. 2010
    ..In addition, they indicate that DUSP26 may function as a tumour suppressor in particular cancers...
  3. doi request reprint Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers
    Brian S Gloss
    Cancer Research Program, The Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia
    Cancer Lett 318:76-85. 2012
    ..05). We propose that this potential biomarker panel holds great promise as a diagnostic test for high-grade (Type II) serous ovarian cancer...